BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lei Y, Sheng JH, Jin XR, Liu XB, Zheng XY, Xu XH. Study on the efficacy of early treatment with pirfenidone on the lung function of patients with idiopathic pulmonary fibrosis. World J Clin Cases 2024; 12(22): 4913-4923 [PMID: 39109030 DOI: 10.12998/wjcc.v12.i22.4913]
URL: https://www.wjgnet.com/2307-8960/full/v12/i22/4913.htm
Number Citing Articles
1
Basma M E Mohamed, Mohamed E A Abdelrahim. Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progressionWorld Journal of Clinical Cases 2024; 12(32): 6538-6542 doi: 10.12998/wjcc.v12.i32.6538
2
Jin-Wei Zhang. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patientsWorld Journal of Clinical Cases 2024; 12(28): 6247-6249 doi: 10.12998/wjcc.v12.i28.6247
3
Li-Ying Xu, Yi Yu, Lu-Sha Cen. Insight into the efficacy and safety of pirfenidone: The treatment of idiopathic pulmonary fibrosisWorld Journal of Clinical Cases 2025; 13(14): 98769 doi: 10.12998/wjcc.v13.i14.98769